MedTrace Logo

The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma

NCT05750797 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800000

Last updated 2023-03-06

No results posted yet for this study

Summary

The Health Insurance Review and Assessment Service (HIRA) database contains nationwide claim data. By utilizing this database, the investigators aimed to analyze the current status of OCS use in South Korea by using HIRA database.

Conditions

Interventions

DRUG

Oral corticosteroids

The prescription of OCS will be analyzed. OCS included betamethasone, deflazacort, dexamethasone, hydrocortisone, methylprednisolone, prednisolone, and triamcinolone.

Sponsors & Collaborators

  • Seoul St. Mary's Hospital

    collaborator OTHER

  • Hallym University Medical Center

    collaborator OTHER

  • Konkuk University Hospital

    collaborator OTHER

  • Joon Young Choi

    lead OTHER

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05750797 on ClinicalTrials.gov